|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02953 IMMUNOTECH-BRTS
Nominal 
0.340 0.000 (0.000%) | 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Turnover | 55,517 | -88.163% | 469,000 | 394,000 | 283,000 | 430,000 |
| Cost of Sales | (118,768) | -72.760% | (436,000) | (419,000) | (259,000) | (393,000) |
| Gross Profit | (63,251) | -- | 33,000 | (25,000) | 24,000 | 37,000 |
| 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (63,285) | 321.900% | (15,000) | 36,000 | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (175,742) | 197.868% | (59,000) | (135,000) | (196,000) | (84,000) | |
| Taxation | (332) | -66.800% | (1,000) | 25,000 | 30,000 | (1,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | (13,000) | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | (2,000) | (3,000) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (176,074) | 193.457% | (60,000) | (123,000) | (168,000) | (88,000) | |
| 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Net Finance Costs / (Income) | 54 | -- | (3,000) | (4,000) | (16,000) | (12,000) |
| Depreciation & Amortisation | 100 | -90.000% | 1,000 | 0 | 3,000 | 2,000 |
| Directors' Emoluments | 6,516 | -47.955% | 12,520 | 10,080 | 17,564 | 19,679 |
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| EPS (cts) | -180.000 | 181.070% | -64.041 | -137.511 | -176.800 | -117.867 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.121) | -- | (0.296) | 0.009 | 0.001 | 0.000 |
| NBV per share ($) | 6.042508 | -- | 9.392347 | 9.894554 | 10.888283 | 12.533814 |
| Remarks: | Real time quote last updated: 30/10/2025 08:47 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -176,074 |
| %Change | 193.457% |
| EPS / (LPS) | HKD -1.800 |
| NBV Per Share ($) | HKD 6.043 |